6KS-89678-85273
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 490 / MI
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
- 2020-12-30
- 2021-01-01
- 2021-01-02
- 2021-01-04
-
2021-01-05
Health check-in — day 7, dose 1Feeling: Good · Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-05
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, NauseaAdult check-in
- 2021-01-23
- 2021-01-25
- 2021-01-28
- 2021-02-03
- 2021-02-09
- 2021-02-16
- 2021-02-24
- 2021-03-02
-
2021-07-22
Survey response — 6 months, dose 2MedDRA: Asthma, Pharyngitis, Pre-existing disease, Viral sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Viral sinusitis, pharyngitis, asthma exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-26
-
2022-01-19
Survey response — 12 months, dose 2MedDRA: Pregnancy, SARS-CoV-2 test negative, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy; viral infection (neg COVID test)MedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-12-11
- 2022-12-18
- 2022-12-23
- 2023-01-01
- 2023-01-06
- 2023-01-14
- 2023-03-03
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2022-12-02 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-05 | priority 2/3 | |
| 2021-07-22 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Viral sinusitis, pharyngitis, asthma exacerbation
Release 10 — 12 months, dose 2
Symptoms: Pregnancy; viral infection (neg COVID test)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Pharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Viral sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release